secwatch.observer — SEC 8-K summary
======================================

Issuer:     ELITE PHARMACEUTICALS INC /NV/ (ELTP)
CIK:        0001053369
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001493152-25-021392
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elite Pharma to release Q2 FY2026 results Nov 14; conference call Nov 17
------------------------------------------------------------------------

- Q2 FY2026 financial results (ended Sep 30, 2025) to be released on Friday, November 14, 2025.
- Management conference call set for Monday, November 17, 2025, at 11:30 AM EST.
- Dial-in numbers: 1-800-346-7359 (domestic), 1-973-528-0008 (international); conference ID 98840.
- Stockholder questions accepted via email (dianne@elitepharma.com) by deadlines listed in release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053369/000149315225021392/0001493152-25-021392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053369/000149315225021392/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-021392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer